Asian Neurostimulation Devices Market - Jsb Market Research

Asian Neuromodulation Devices Market

Released On 9th July 2015

The Internal Neuromodulation market is estimated to register a CAGR of 13.8% during the forecast period. Rise in the incidences and prevalence of neurological diseases, rapid growth in aging population, development of advanced neurostimulation technologies, and increasing awareness are some of the key factors that are fueling the growth of the neuromodulation technologies market. However, lack of skilled professionals and unfavorable reimbursement scenario are some of the key challenges faced by the market players.

 The emerging markets including China and India have become the key growth segments for the companies engaged in the development and marketing of the Internal Neuromodulation implants. Rising incidences of neurological disorders and government initiatives to increasing awareness by education campaigns are the key factors propelling the demand of neurological devices and technologies in the emerging markets.

Medtronic, Inc. (U.S.) held the leading position in the Asia-Pacific Internal Neuromodulation Devices market. In recent years, the company has adopted expansion of its R&D capabilities, new product launches, and geographical expansion as its key business strategies to ensure its dominant position in this market. St. Jude Medical Inc. (U.S.) and Boston Scientific Inc. (U.S.) are some other key players competing in the Asia-Pacific Internal Neuromodulation market.

 Scope of the Report

 This research categorizes the Asia-Pacific Internal Neuromodulation market report  into the following segments and subsegments:

 Asia-Pacific Internal Neuromodulation Market Report, by Modality

 Spinal Cord Stimulator

 Deep Brain Stimulator

 Sacral Nerve Stimulator

 Vagus Nerve Stimulator

 Gastric Neurostimulator

 Asia-Pacific Internal Neuromodulation Market Report, by Application

 Spinal Cord Stimulator

 Chronic Pain

 Failed back surgery syndrome

 Ischemic...